| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
APASL consensus statements and recommendation on treatment of hepatitis C
|
Omata, Masao
|
|
2016
|
10 |
5 |
p. 702-726
|
artikel
|
| 2 |
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing
|
Omata, Masao
|
|
2016
|
10 |
5 |
p. 681-701
|
artikel
|
| 3 |
A randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatment
|
Takami, Yuko
|
|
2016
|
10 |
5 |
p. 799-806
|
artikel
|
| 4 |
End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients
|
Ahn, Joseph
|
|
2016
|
10 |
5 |
p. 838-846
|
artikel
|
| 5 |
Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure
|
Zoulim, Fabien
|
|
2016
|
10 |
5 |
p. 779-788
|
artikel
|
| 6 |
HBsAg loss in a New Zealand community study with 28-year follow-up: rates, predictors and long-term outcomes
|
Lim, Tien Huey
|
|
2016
|
10 |
5 |
p. 829-837
|
artikel
|
| 7 |
HBsAg loss in chronic hepatitis B: pointers to the benefits of curative therapy
|
Dusheiko, Geoffrey
|
|
2016
|
10 |
5 |
p. 727-729
|
artikel
|
| 8 |
Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals
|
Colpitts, Che C.
|
|
2016
|
10 |
5 |
p. 741-748
|
artikel
|
| 9 |
Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise
|
Liamis, G.
|
|
2016
|
10 |
5 |
p. 762-772
|
artikel
|
| 10 |
Incidence, risk factors and outcomes of acute kidney injury (AKI) in patients with acute-on-chronic liver failure (ACLF) of underlying cirrhosis
|
Zang, Hong
|
|
2016
|
10 |
5 |
p. 807-818
|
artikel
|
| 11 |
Management of post liver transplantation recurrent hepatitis C infection with directly acting antiviral drugs: a review
|
Jothimani, Dinesh
|
|
|
10 |
5 |
p. 749-761
|
artikel
|
| 12 |
Management of post liver transplantation recurrent hepatitis C infection with directly acting antiviral drugs: a review
|
Jothimani, Dinesh
|
|
2016
|
10 |
5 |
p. 749-761
|
artikel
|
| 13 |
New approaches for fibrosis regression in alcoholic cirrhosis
|
Mehal, Wajahat
|
|
2016
|
10 |
5 |
p. 773-778
|
artikel
|
| 14 |
New approaches for fibrosis regression in alcoholic cirrhosis
|
Mehal, Wajahat
|
|
|
10 |
5 |
p. 773-778
|
artikel
|
| 15 |
Renin–angiotensin system inhibitors and fibrosis in chronic liver disease: a systematic review
|
Kim, Gaeun
|
|
2016
|
10 |
5 |
p. 819-828
|
artikel
|
| 16 |
Targeting the renin–angiotensin system in liver fibrosis
|
Sancho-Bru, Pau
|
|
2016
|
10 |
5 |
p. 730-732
|
artikel
|
| 17 |
The role of bile salts in liver regeneration
|
Laarschot, Liyanne F. M. van de
|
|
2016
|
10 |
5 |
p. 733-740
|
artikel
|
| 18 |
Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patients
|
Ji, Dong
|
|
2016
|
10 |
5 |
p. 789-798
|
artikel
|
Tijdschrift beschrijving